CTRI/2017/08/009402已完成未知
â??Comparison of Efficacy of Hepatitis B Vaccination during Induction with Maintenance Phase of Chemotherapy in Acute Lymphoblastic Leukemia.â??
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- JIPMER
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Newly diagnosed acute lymphoblastic leukemia patients attending JIPMER medicine/ medical oncology OPD
- •2) Receiving chemotherapy (in either induction phase or Maintenance phase)
- •3) Seronegative for HBsAg
- •4) Anti HBs < 10 mIU/ml
- •5) Normal liver function test
排除标准
- •1) Patients already having Hepatitis B infection
- •2) Patients with immunocompromised state due to any other reason (e.g. HIV)
研究者
相似试验
已完成
不适用
the effect of Hepatitis B vaccination in patients with chronic kidney diseaseChronic renal failure.Chronic renal failureIRCT138905163325N4Zanjan University of Medical Sciences51
已完成
不适用
The Efficacy of Hepatitis B Virus (HBV) Vaccination in Patients with Previously Resolved HBV Infection Receiving Immunosuppressive Therapy to Prevent HBV Reactivation through Increase of Serum Levels of Anti-HBs (Pilot Study)Collagen disease, collagen disease related disease, ulcerative colitis, Crohn's disease, intestinal Behcet's disease (simple ulcers included), psoriasis, and diseases that require other immunosuppressive therapies.JPRN-UMIN000042288Saitama Medical University13
已完成
2 期
Comparing the Efficacy and Safety of Hepatitis B vaccine of Pasteur Institute of Iran and Cuban Heber biotec Company’s in Iranian healthy volunteersCondition 1: Acute Hepatitis B. Condition 2: Chronic (viral) hepatitis B.Acute hepatitis BChronic (viral) hepatitis BIRCT201109113307N5Pasteur Institute of Iran (IPI)440
已完成
不适用
Comparison of effectiveness of hepatitis B revaccination schemes in healthy non-respondershepatitis B vaccine non-response10047438NL-OMON41474eids Universitair Medisch Centrum480
进行中（未招募）
1 期
Comparison of 4 different Hepatitis B vaccines in healthy persons in whom a standard hepatitis B vaccination schedule of three vaccinations did not induces a protective immune response, so-called non-responders.EUCTR2011-005627-40-NL480